Chemoinformaics analysis of Secoisolariciresinol
| Molecular Weight | 362.422 | nRot | 9 |
| Heavy Atom Molecular Weight | 336.214 | nRig | 12 |
| Exact Molecular Weight | 362.173 | nRing | 2 |
| Solubility: LogS | -2.936 | nHRing | 0 |
| Solubility: LogP | 1.589 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 52 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 26 | No. of Aromatic Carbocycles | 2 |
| nHetero | 6 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 26 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 20 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 6 | No. of Arom Bond | 12 |
| nHA | 6 | APOL | 55.5486 |
| nHD | 4 | BPOL | 29.5554 |
| QED | 0.545 |
| Synth | 3.112 |
| Natural Product Likeliness | 0.765 |
| NR-PPAR-gamma | 0.016 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.003 |
| Pgp-sub | 0.074 |
| HIA | 0.459 |
| CACO-2 | -4.557 |
| MDCK | 0.00000735 |
| BBB | 0.039 |
| PPB | 0.918779 |
| VDSS | 0.601 |
| FU | 0.0525959 |
| CYP1A2-inh | 0.487 |
| CYP1A2-sub | 0.939 |
| CYP2c19-inh | 0.132 |
| CYP2c19-sub | 0.764 |
| CYP2c9-inh | 0.258 |
| CYP2c9-sub | 0.807 |
| CYP2d6-inh | 0.608 |
| CYP2d6-sub | 0.922 |
| CYP3a4-inh | 0.548 |
| CYP3a4-sub | 0.757 |
| CL | 14.552 |
| T12 | 0.915 |
| hERG | 0.091 |
| Ames | 0.089 |
| ROA | 0.023 |
| SkinSen | 0.736 |
| Carcinogencity | 0.075 |
| EI | 0.387 |
| Respiratory | 0.033 |
| NR-Aromatase | 0.8 |
| Antiviral | No |
| Prediction | 0.677641 |